Citizen Meds review
The entry figure is stated, and so is the fact that it rises with the dose. Most sellers state only the first half.
The verdict
Citizen Meds publishes $135 a month for compounded semaglutide at the entry dose. It states plainly that the figure rises as the dose does, which is a disclosure most sellers here do not make.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Rises with dose
- From
- From $135/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Citizen Meds sells compounded semaglutide and compounded tirzepatide by injection. Each carries an entry figure and a stated intention to rise.
Who writes the prescription, and what do they see?
A prescription precedes shipping, and the pages describe the plan rather than the clinician writing it. The intake is not documented. What the seller does document is the pricing behavior, which is the thing a buyer meets second.
The service is remote. The pages are organized around dose tiers rather than around a care relationship, and nothing describes what a clinician reviews between one tier and the next.
What happens when the dose goes up?
This is the field Citizen Meds actually answers. The entry figure is for the starting dose and the seller says the charge moves upward with the milligrams. It does not publish every rung, so a buyer knows the direction without knowing the destination. Direction is more than silence and less than a ladder.
What the price includes
$135 buys the first dose tier and nothing here fixes it there. Six months at the entry figure is $810, and that total holds only for a buyer who does not escalate — which describes almost nobody in the first four months. Tirzepatide starts at $157 under the same rule.
What it claims, and what it cites
Both lines are compounded rather than manufactured. A pharmacy prepares them and the FDA does not review them before dispensing. No pharmacy is named on the pages.
Where it holds up, and where it does not
- Strength: States that the price rises with dose
- Strength: Entry figures published for both molecules
- Strength: Tirzepatide costs only $22 more to start
- Limitation: The upper rungs are not published
- Limitation: No state coverage list is recorded
- Limitation: The entry total misleads anyone escalating
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about Citizen Meds. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A buyer who wants the escalation named rather than discovered on a card statement.
- Wrong for
- A buyer who needs to know the cost at 2.4 milligrams before committing.
The evidence behind what Citizen Meds prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Citizen Meds compares
| Seller | Who it suits | Go |
|---|---|---|
 Bloom MD | Buyers who want each tirzepatide dose priced in advance, with liraglutide as an option | See Bloom MD → |
 Belle Health | Someone who wants included nutrition and clinical support and can choose an appropriate supply commitment after discussing treatment. | See Belle Health → |
 Bon Health | Readers who can pick a commitment length and want every rung priced before they choose | See Bon Health → |
More GLP-1 telehealth sellers reviews: KIN HealthKlarity HealthKlinicKovaLifeVine WellnessLighter You
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Does $135 hold at a higher dose?
- No, and Citizen Meds says so. The figure is the entry dose and the charge rises with the milligrams. What it rises to is not published.
- What does tirzepatide cost?
- $157 at the entry dose, under the same rising structure as the semaglutide line.
- Is a rising price a bad sign?
- Not by itself. Saying so is a disclosure, and most compounded sellers publish nothing about what happens at a higher dose.
- Is Citizen Meds expensive compared with other GLP-1 telehealth sellers?
- Citizen Meds publishes a starting figure of $135/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Citizen Meds below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.